June 13, 2022
Pharmaceuticals and Medical Devices Agency
Globalization of research and development, manufacturing and marketing of medical products has progressed, and cooperation in regulatory activities amongst regulatory agencies has become more and more important. Nowadays, Asian countries have become significant in the area of clinical development and manufacturing of medical products, and therefore, PMDA strives to strengthen the collaborative relationship with the Asian regulatory agencies.
PMDA and the National Pharmaceutical Regulatory Agency (NPRA) held the 1st Malaysia-Japan Symposium in 2015. This symposium is planned and organized to tighten the mutual relationship and the cooperative framework for regulation of medical products and to promote thorough understanding of regulatory systems of the two host countries.
This symposium will offer in-depth presentations and discussions in each area from the pharmaceutical regulatory perspective.
Pharmaceuticals and Medical Devices Agency (PMDA)
National Pharmaceutical Regulatory Agency (NPRA)
Japan Pharmaceutical Manufacturers Association (JPMA)
Forum for Innovative Regenerative Medicine (FIRM)
Malaysian Pharmacist’s Society (MPS)
14th July, 2022
The symposium will be held by virtual (WebEx).
Participants will receive the link by email.
Registration is now closed
|Online Registration||Click : https://forms.gle/Hu4PKfnVkE61uTzQA|
|Deadline||28th June, 2022|
* Please note the number of participants is limited. In case the number of applicant is exceed the capacity, we may not be able to meet a request.
Simultaneous interpretation (English-Japanese/Japanese-English)
Please see attached, for the details of the program.